A potential explanation is that subtly elevated Aβ levels (i.e., all CBS patients were by definition Aβ-negative), which have been previously shown to accelerate AD-typical tau spreading52, also accelerate subcortical to cortical tau spreading in CBS patients. This evidence concerns the gene MAPT and Alzheimer disease.